≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Hyperprolactinaemia

DOID EFO MESH SNOMED PheWeb

E4_HYPERPRO

hyperprolactinemia: An acquired metabolic disease that has_material_basis_in the presence of abnormally-high levels of prolactin in the blood.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 E22.1#
Hospital discharge: ICD-9 2531A
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 E22.1#
Cause of death: ICD-9 2531A
Cause of death: ICD-8 $!$

963

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

963

diagram downward connector

Check minimum number of events None

963

diagram downward connector

Include endpoints None

963

diagram downward connector
E4_HYPERPRO

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 E22
Name in latin Hyperprolactinaemia

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 963 806 157
Unadjusted prevalence (%) 0.27 0.41 0.10
Mean age at first event (years) 37.85 35.55 49.62

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 3.99 [2.03, 7.85] 6.0e-5 25
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: E4_HYPERPRO – Hyperprolactinaemia
GWS hits:

Survival analyses between endpoints

↥

Plot

before Hyperprolactinaemia
after Hyperprolactinaemia

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Hyperprolactinaemia

↥